Assessing Symptoms, Disease Severity, and Quality of Life in the Clinical Context: A Theoretical Framework

American Journal of Managed Care

Volumn 10, Issue 5, 2004, Pages 336-344

  Finlayson, Tracy L ^a   Moyer, Cheryl A ^b   Sonnad, Seema S ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; HEALTH ECONOMICS; HEALTH SERVICE; MEASUREMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; THEORETICAL STUDY;

GASTROESOPHAGEAL REFLUX; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HUMANS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES; UNITED STATES; URINARY INCONTINENCE;

EID: 2442435640     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Mechanic D. The concept of illness behavior: culture, situation and personal predisposition. Psychol Med. 1986;16:1-7.
2. Mechanic D. Social psychologic factors affecting the presentation of bodily complaints. N Engl J Med. 1972;286:1132-1139.
3. Spilker B, ed. Introduction. In: Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1996:1-10.
4. Wood-Dauphinee S. Assessing quality of life in clinical research: from where we come and where we are going? J Clin Epidemiol. 1999;52:355-363.
5. Ware JE. Standards for validating health measures: definition and content. J Chronic Dis. 1987;40:473-480.
6. Andrews FM, ed. Research on the Quality of Life. Ann Arbor: Institute of Social Research, University of Michigan; 1986.
7. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurements in clinical trials: choosing the right approach. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1996:41-48.
8. World Health Organization. Constitution of the World Health Organization. In: Basic Documents. Geneva, Switzerland: World Health Organization; 1948.
9. Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med. 2001;2:477-491.
10. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality of life instruments: attributes and review criteria. Quality of Life Res. 2002;11:193-205.
11. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PMM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res. 2003;12:349-362.
12. Osoba D. A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of results. Med Care. 2002;40(suppl):III31-III38.
13. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 1998;17:1191-1194.
14. Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer. 2001;37:1331-1334.
15. Schipper HL, Clinch JJ, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1996:11-23.
16. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273:59-65.
17. Abrams P, Blaivas JG, Stanton SL, Andersen JT, International Continence Society Committee on Standardisation of Terminology. The standardisation of terminology of lower urinary tract function. Scand J Urol Nephrol Suppl. 1988;114:5-19.
18. Kelleher CJ, Cardozo LD, Toozs-Hobson PM. Quality of life and urinary incontinence. Curr Opin Obstet Gynecol. 1995;7:404-408.
19. Groutz A, Blaivas JG, Rosenthal JE. A simplified urinary incontinence score for the evaluation of treatment outcomes. Neurourol Urodyn. 2000;19:127-135.
20. Seim A, Hermstad R, Hunskaar S. Management in general practice significantly reduced psychosocial consequences of female urinary incontinence. Qual Life Res. 1997;6:257-264.
21. Molander U, Milsom I, Ekelund P, Arvidsson L, Eriksson O. A health care program for the investigation and treatment of elderly women with urinary incontinence and related urogenital symptoms. Acta Obstet Gynecol Scand. 1991;60:137-142.
22. Dupont MC, Albo ME, Raz S. Diagnosis of stress urinary incontinence: an overview. Urol Clin N Am. 1996;23:407-415.
23. Harris A. Impact of urinary incontinence on the quality of life of women. Br J Nurs. 1999;8:375-380.
24. Donovan JL, Abrams P, Peters TJ, et al. The ICS-"BPH" Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996;77:554-562.
25. Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. Psychosocial impact of urinary incontinence in women. Obstet Gynecol. 1987;70(pt 1):378-381.
26. Langro-Janssen A, Debruyne F, Van Weel C. Value of the patient's case history in diagnosing urinary incontinence in general practice. Br J Urol. 1991;67:569-572.
27. Ishiko O, Hirai K, Sumi T, Nishimura S, Ogita S. The urinary incontinence score in diagnosis of female urinary incontinence. Int J Gynaecol Obstet. 2000;68: 131-137.
28. Sandvik H, Seim A, Vanvik A, Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests. Neurourol Urodyn. 2000;19:137-145.
29. Bo K. Reproducibility of instruments designed to measure subjective evaluation of female stress urinary incontinence. Scand J Urol Nephrol. 1994;28:97-100.
30. Norton C. The effects of urinary incontinence in women. Int Rehab Med. 1982;4:9-14.
31. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA, Continence Program in Women (CPW) Research Group. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res. 1994;3:291-306.
32. Uebersax IS, Wyman IF, Shumaker SA, McClish DK, Fantl JA, Continence Program for Women Research Group. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Neurourol Urodyn. 1995;14:131-139.
33. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805-812.
34. Donovan JL, Kay HE, Peters TJ, et al, International Continence Society-Benign Prostatic Hyperplasia. Using the ICSQOL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-"BPH" Study. Br J Urol. 1997;80:712-721.
35. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328: 1230-1235.
36. Victor LD. Obstructive sleep apnea. Am Fam Physician. 1999;60:2279-2286.
37. Redline S, Young T. Epidemiology and natural history of obstructive sleep apnea. Ear Nose Throat J. 1993;72:20-26.
38. Chervin RD, Aldrich MS. The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea. Neurology. 1999;52:125-131.
39. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:461-467.
40. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick M. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea. Chest. 1999;115:771-781.
41. Piccirillo JF, Gates GA, White DL, Schectman KB. Obstructive sleep apnea treatment outcomes pilot study. Otolaryngol Head Neck Surg. 1998;118:833-844.
42. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
43. Mitler MM, Gujavarty KS, Browman CP. Maintenance of Wakefulness Test: a polysomnographic technique for evaluating treatment in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol. 1982;53:658-661.
44. Carskadon MA, Dement W, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519-524.
45. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-843.
46. Dodds WJ. The pathogenesis of gastroesophageal reflux disease. Am J Roentgenol. 1988;151:49-56.
47. Silva MAGS, Damante JH, Stipp AC, Tolentino MM, Carlotto PR, Fleury RN. Gastroesophageal reflux disease: new oral findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:301-310.
48. Svedlund J, Sjodin I, Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129-134.
49. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther. 1998;12:1257-1262.
50. Garratt AM. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol. 1996;49:565-571.
51. El-Omar EM, Banerjee S, Wirz A, McColl KE. The Glasgow Dyspepsia Severity Score: a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996;8:967-971.
52. Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis. 1998;16:315-324.
53. Eypasch E, Williams JI, Wood-Dauhinee S, et al. Gastrointestinal Quality of Life Index: development, validation, and application of a new instrument. Br J Surg. 1995;82:216-222.
54. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217-224.
55. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
56. Irvine EJ, Zhou Q, Thompson AK, Canadian Crohn's Relapse Prevention Trial Investigators. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571-1578.
57. Guyatt G, Mitchell A, Irvine JE, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-810.
58. Chassany O, Bergmann JF. Quality of life in irritable bowel syndrome: effect of therapy. Eur J Surg Suppl. 1998;583:81-86.
59. Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients: psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;583:41-49.
60. Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13:225-235.
61. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750-S756.
62. Maunder RG, Cohen Z, McLeod RS, Greenberg GR. Effect of intervention in inflammatory bowel disease on health-related quality of life: a critical review. Dis Colon Rectum. 1995;38:1147-1161.
63. Flemons WW. Measuring health related quality of life in sleep apnea. Sleep. 2000;23(suppl 4):S109-S114.
64. Irvine EI. Measuring quality of life: a review. Scand J Gastroenterol Suppl. 1996;31:5-7.